STAYVEER 125 MG TBL FLM 56

Show dosage form

What is the maximum co-payment for STAYVEER?

If the insurance company contributes, the maximum co-payment is 6 786,87 Kč. The maximum pharmacy price is 21 844,99 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does STAYVEER have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

15 058,12 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Medicinal products s obsahem bosentanu jsou hrazeny:
a) k léčbě pacientů s arteriální plicní hypertenzí ve funkční třídě III. dle klasifikace NYHA
b) k prevenci vzniku nových ulcerací u pacientů s mnohočetnými aktivními digitálními ulceracemi (minimálně 3 vředy na počátku léčby) provázejícími všechny formy systémové sklerodermie. Léčba bosentanem je ukončena v případě, že po čtyřech měsících léčby dochází ke vzniku nových digitálních ulcerací.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe STAYVEER?

Prescription is not conditional on a medical specialization.

What is the composition of STAYVEER?

Monohydrát bosentanu, bosentan (125 mg), kukuřičný škrob, neznámá látka s kódem 5214, neznámá látka s kódem 14679, povidon, neznámá látka s kódem 16007, magnesium-stearát, hypromelosa, neznámá látka s kódem 4105, ointmentek, oxid titaničitý, žlutý oxid železitý, červený oxid železitý, neznámá látka s kódem 4065. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to STAYVEER?

The medicine belongs to ATC group C02KX01 – BOSENTAN. Medicines with the same active substance can be found here.

Who manufactures STAYVEER?

Janssen-Cilag International N.V., Beerse (B)

Is the medicine in shortage?

The latest report from the manufacturer is from 6. 6. 2025. Production was terminated with effect from 31. 8. 2026. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for STAYVEER?

The medicine has code 0219036. Code details can be found here.

How many packs of STAYVEER were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of STAYVEER were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

PODOBNÉ PŘÍPRAVKY:

The page was last updated on 03. 05. 2026

SIMILAR MEDICINES: